Newark, CA, United States of America

Kai Wang

This inventor holds 2 USPTO granted patents. Top assignee: Applied Stemcell, Inc.. Active years: 2024-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kai Wang. Retrieved from https://idiyas.com/inventor/kai-wang-9hn0ac03

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2024-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Inventor Kai Wang

Introduction

Kai Wang is an accomplished inventor based in Newark, California. He has made significant contributions to the field of cell transplantation therapy. His innovative work focuses on enhancing the efficacy of donor cells through genetic modifications.

Latest Patents

Kai Wang holds a patent for "HLA-F-modified cells and methods." This patent provides compositions and methods for cell transplantation therapy based on the forced expression of an exogenous HLA-F protein in donor cells. The invention aims to improve the compatibility and success of cell transplants in subjects. In particular, the donor cells express an exogenous chimeric HLA-F protein that includes various components essential for effective transplantation.

Career Highlights

Kai Wang is associated with Applied Stemcell, Inc., where he continues to advance research in stem cell technology and transplantation methods. His work has the potential to revolutionize treatments for various medical conditions requiring cell therapy.

Collaborations

Some of his notable coworkers include Ruby Yanru Tsai and Alfonso Farruggio. Their collaborative efforts contribute to the innovative environment at Applied Stemcell, Inc.

Conclusion

Kai Wang's contributions to the field of cell transplantation therapy exemplify the impact of innovative thinking in medical science. His patent on HLA-F-modified cells showcases the potential for improved transplant outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…